PetMed Express financials
$1.40−0.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q1 '27 Jun 30 | Q4 '26 Mar 31 | Q3 '26 Dec 31 | Q2 '26 Sep 30 | Q1 '26 Jun 30 | Q4 '25 Mar 31 | Q3 '25 Dec 31 | Q2 '25 Sep 30 | Q1 '25 Jun 30 | Q4 '24 Mar 31 | Q3 '24 Dec 31 | Q2 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.0M | $42.8M | $40.7M | $44.4M | $51.2M | $50.8M | $52.0M | $58.0M | $66.2M | $59.5M | $65.3M | $71.0M |
| Gross profit | $11.3M | $16.1M | $9.5M | $12.4M | $14.4M | $15.2M | $16.1M | $18.8M | $19.0M | $24.3M | $17.9M | $20.1M |
| Gross margin | 27.6% | 37.5% | 23.3% | 28.0% | 28.1% | 29.9% | 31.0% | 32.3% | 28.8% | 40.8% | 27.4% | 28.3% |
| Operating income | -$6.2M | -$5.7M | -$10.5M | -$8.4M | -$34.1M | -$6.0M | -$450.0K | $554.0K | $4.4M | -$3.8M | -$3.1M | $875.0K |
| Net income | -$6.1M | -$4.1M | -$10.6M | -$8.5M | -$34.2M | -$11.6M | -$707.0K | $2.3M | $3.8M | -$5.0M | -$2.0M | $715.0K |
| Net margin | −15.0% | −9.5% | −26.0% | −19.2% | −66.7% | −22.9% | −1.4% | 4.0% | 5.7% | −8.4% | −3.1% | 1.0% |
| Diluted EPS | $-0.28 | $-0.19 | $-0.50 | $-0.41 | $-1.65 | $-0.59 | $-0.03 | $0.11 | $0.18 | $-0.25 | $-0.10 | $0.03 |
| EBITDA | -$4.1M | -$1.1M | -$8.1M | -$6.1M | -$4.6M | -$2.7M | $1.1M | $2.2M | $6.1M | -$3.8M | -$1.3M | $2.6M |
| Operating cash flow | -$7.7M | -$4.7M | -$9.2M | -$2.2M | -$12.3M | $7.0M | -$1.2M | $7.4M | -$8.5M | $7.1M | -$2.6M | -$777.0K |
| Free cash flow | -$8.3M | -$5.5M | -$9.2M | -$4.8M | -$13.6M | $4.6M | -$1.9M | $6.1M | -$9.2M | $5.9M | -$3.7M | -$1.8M |
| Diluted shares | 21.7M | 21.0M | 21.0M | 20.9M | 20.8M | 19.9M | 20.6M | 20.9M | 20.9M | 20.0M | 20.4M | 20.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.1M | $21.4M | $26.9M | $36.1M | $41.1M | $54.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $63.8M | $81.2M | $88.0M | $100.3M | $109.8M | $148.7M |
| Total liabilities | $40.8M | $52.3M | $55.2M | $57.2M | $58.3M | $63.6M |
| Shareholders' equity | $23.0M | $28.9M | $32.8M | $43.1M | $51.5M | $85.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology